blindness from glp-1 People Going Blind GLP-1: Risks, Evidence and Protection – Bolt Pharmacy Seeing scary posts about GLP-1

GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons

GLP-1RAs show promise in managing RA and cardiometabolic health The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) was associated with improvements in both rheumatoid arthritis (RA) disease activity and cardiovascular risk factors among people living with overweight or obesity, according to new research published in ACR Open Rheumatology

The Need for Effective Weight Loss Medication I recently saw a headline arguing that GLP-1 agonists are an even more revolutionary advance than certain aspects of artificial intelligence

[DOI] [PubMed] [Google Scholar] 70.National Cancer Institute

doi: 10.1097/ADM.0b013e3181ce38e7

Multidisciplinary nutrition care: Benefitting patients with malnutrition across healthcare sectors